Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
OncoSil Medical Ltd ( (AU:OSL) ) has provided an announcement.
OncoSil Medical Ltd has announced the application for quotation of new securities on the Australian Securities Exchange (ASX), including 7,740 ordinary fully paid shares and 7,740 options expiring in July 2027. This move is part of the company’s strategic efforts to enhance its financial position and support its ongoing operations in the medical device sector, potentially impacting its market presence and offering new opportunities for stakeholders.
More about OncoSil Medical Ltd
OncoSil Medical Ltd operates in the medical industry, focusing on the development and commercialization of medical devices for the treatment of cancer. Their primary product is a targeted radioactive implant designed to treat pancreatic and liver cancer, aiming to improve patient outcomes in these challenging areas.
Average Trading Volume: 42,579
Technical Sentiment Signal: Strong Sell
Current Market Cap: A$21.26M
See more data about OSL stock on TipRanks’ Stock Analysis page.